Form 4 for RMD ResMed|
Accepted 2022-12-06 00:00:00 ET · period of report 2022-12-05 · accession 0001127602-22-026963 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-06 | 2022-12-05 | RMD | PENDARVIS DAVID | Chief Administrative Off | S - Sale | $229.81 | -1,500 | 98.7K | -1% | -$344.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2022-12-05 | S | D | 1,500 | $229.81 | 98,672 | D | — | — |